Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices 435 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Initial 

Review Group; Arthritis and Musculoskeletal 

and Skin Diseases Clinical Trials Review 

Committee. 

Date: February 7, 2019. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Canopy by Hilton, 940 Rose Avenue, 

North Bethesda, MD 20852. 

Contact Person: Nakia C. Brown, Ph.D., 

Scientific Review Officer, 6701 Democracy 

Blvd., RM 816, Bethesda, MD 20892, 301– 

827–4905, brownnac@mail.nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: January 18, 2019. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00168 Filed 1–25–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Synthetic and Biological 

Chemistry A Study Section. 

Date: January 31–February 1, 2019. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Spero, 405 Taylor Street, San 

Francisco, CA 94102. 

Contact Person: Anita Szajek, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4187, 

Bethesda, MD 20892, 301–827–6276, 

anita.szajek@nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 18, 2019. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00171 Filed 1–25–19; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; SBIR PHS 2019–1 Topic 

070—Development of Sample Sparing 

Assays. 

Date: February 7, 2019. 

Time: 12:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Julio C. Aliberti, Ph.D., 

Scientific Review Officer, Immunology 

Review Branch, DEA/SRP RM 3G53A, 

National Institutes of Health, NIAID, 5601 

Fishers Lane, MSC 9823, Rockville, MD 

20892–9823, 301–761–7322, julio.aliberti@

nih.gov. 

This meeting notice is being published less 

than 15 days in advance of the meeting due 

to the partial Government shutdown of 

December 2018. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 18, 2019. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2019–00165 Filed 1–25–19; 8:45 am] 

BILLING CODE 4140–01–P 

LIBRARY OF CONGRESS 

U.S. Copyright Office 

[Docket No. 2019–1] 

Notice of Intent To Audit 

AGENCY: U.S. Copyright Office, Library 

of Congress. 

ACTION: Public notice. 

SUMMARY: The U.S. Copyright Office is 

announcing receipt of five notices of 

intent to audit certain statements of 

account filed by cable operators and a 

satellite carrier pursuant to the section 

111 and 119 statutory licenses. 

FOR FURTHER INFORMATION CONTACT: 

Regan A. Smith, General Counsel and 

Associate Register of Copyrights, by 

email at regans@copyright.gov, or Anna 

Chauvet, Assistant General Counsel, by 

email at achau@copyright.gov. Either 

can be contacted by telephone by calling 

(202) 707–8350. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Sections 111 and 119 of the Copyright 

Act (‘‘Act’’), title 17 of the United States 

Code, establish compulsory licenses 

under which cable operators and 

satellite carriers may, by complying 

with the license terms, retransmit 

copyrighted over-the-air broadcast 

programming. Among other 

requirements, cable and satellite 

licensees must file statements of 

account and deposit royalty fees with 

the U.S. Copyright Office (‘‘Office’’) on 

a semi-annual basis. 


amozie on DSK3GDR082PROD with NOTICES1